Famotidine Tablets USP, 20 mg

Manufacturer: Wockhardt USA LLC. | Wockhardt Limited
Effective date: 2019-11-26
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: legacy-cache
Hydrated at: 2026-08-01 23:57:30

Label at a glance#

ProductFAMOTIDINE

Active ingredientFAMOTIDINE

Label structure10 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

Dosage and administration

● adults and children 12 years and over: ● to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. ● to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn ● do not use more than 2 tablets in 24 hours ● children under 12 years: ask a doctor

Contacts and useful links#

PhoneLabel contact1-800-346-6854

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Famotidine USP 20 mg

OTC - PURPOSE SECTION

Acid reducer

USES

INDICATIONS & USAGE SECTION

relieves heartburn associated with acid indigestion and sour stomach
prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

WARNINGS

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

DO NOT USE

● if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.

● if you have kidney disease, except under the advice and supervision of a doctor

● with other acid reducers

ASK A DOCTOR BEFORE USE IF YOU HAVE

● had heartburn over 3 months. This may be a sign of a more serious condition.

● heartburn with lightheadedness, sweating or dizziness

● chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

● frequent chest pain

● frequent wheezing, particularly with heartburn

● unexplained weight loss

● nausea or vomiting

● stomach pain

Stop use and ask a doctor if

● your heartburn continues or worsens

● you need to take this product for more than 14 days

PREGNANCY OR BREAST FEEDING

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

● adults and children 12 years and over:

● to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.

● to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn

● do not use more than 2 tablets in 24 hours

● children under 12 years: ask a doctor

OTHER INFORMATION

OTHER SAFETY INFORMATION

● read the directions and warnings before use

● store at 20°-25°C (68°-77°F)

● keep the carton. It contains important information.

● protect from moisture

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Hydroxypropyl cellulose, hypromellose, microcrystalline cellulose, magnesium stearate, polyethylene glycol, pregelatinized starch, talc and titanium dioxide.

QUESTIONS OR COMMENTS

OTC - QUESTIONS SECTION

Call 1-800-346-6854

SPL UNCLASSIFIED SECTION

Manufactured by:

Wockhardt Limited,

Mumbai, India.

Distributed by:

Wockhardt USA LLC.

20 Waterview Blvd.

Parsippany, NJ 07054

USA.

Iss.130810

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Famotidine Tablets USP, 20 mg (OTC)

20 mg – Acid reducer

64679-374-05

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
64679-374-00	2024-11-14	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-01	2024-11-14	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-05	2024-11-14	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-07	2024-11-14	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-08	2024-11-14	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-09	2024-11-14	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-00	2022-07-29	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-01	2022-07-29	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-05	2022-07-29	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-07	2022-07-29	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-08	2022-07-29	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg
64679-374-09	2022-07-29	C162847	48780-1	e4f33bdf-9c33-d8a0-e053-dadaa90a6e4e	Famotidine Tablets USP, 20 mg

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
FAMOTIDINE	ACTIVE INGREDIENT	5QZO15J2Z8	2
FAMOTIDINE	ACTIVE MOIETY	5QZO15J2Z8	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	2
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	2
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

FAMOTIDINE
CELLULOSE, MICROCRYSTALLINE
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
HYPROMELLOSE 2910 (6 MPA.S)
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL 400
STARCH, CORN
TALC
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
64679-374	64679-374-01, 64679-374-08, 64679-374-05, 64679-374-07, 64679-374-00, 64679-374-09

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
FAMOTIDINE	5QZO15J2Z8	ACTIB
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	2165RE0K14	IACT
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
POLYETHYLENE GLYCOL 400	B697894SGQ	IACT
STARCH, CORN	O8232NY3SJ	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 220 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
TALC	TALC	7SEV7J4R1U	TABLET / SUBLINGUAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, DELAYED RELEASE / ORAL		349 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
STARCH, CORN	STARCH, CORN	O8232NY3SJ	INSERT / VAGINAL		147 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		174 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET, EXTENDED RELEASE / ORAL		85 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	DROPS / ORAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
STARCH, CORN	STARCH, CORN	O8232NY3SJ	TABLET, COATED / ORAL		256 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, DELAYED RELEASE / ORAL		420 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	LOZENGE / ORAL		50 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GRANULE / ORAL		322 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET, ORALLY DISINTEGRATING / ORAL		39 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	CAPSULE / ORAL		600 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CREAM / TOPICAL	10 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, DELAYED RELEASE PARTICLES / ORAL		580 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	POWDER / TOPICAL		9235 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET, DELAYED RELEASE / ORAL		77 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	OINTMENT / TOPICAL	74.6 %w/w		Exact identifier — unii candidate 35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	GEL / VAGINAL		1250 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	CAPSULE, DELAYED RELEASE PELLETS / ORAL		261 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, EXTENDED RELEASE / ORAL		90 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		615 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET / ORAL		880 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE / ORAL		72 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CREAM / TOPICAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GUM, CHEWING / BUCCAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CONCENTRATE / ORAL		3000 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / ORAL	1000 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	GRANULE, FOR SUSPENSION / ORAL		42 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, ORALLY DISINTEGRATING / ORAL		6 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, EXTENDED RELEASE / ORAL		67 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	SUSPENSION / ORAL		1600 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	WAFER / ORAL	66 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
STARCH, CORN	STARCH, CORN	O8232NY3SJ	TABLET, FILM COATED / ORAL		2000 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	FILM, EXTENDED RELEASE / TRANSDERMAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CAPSULE / ORAL		13440 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, COATED / ORAL		87 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	GRANULE, FOR SUSPENSION / ORAL		143 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, DELAYED RELEASE / ORAL		35 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, DELAYED RELEASE / ORAL		366 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / BUCCAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE	2165RE0K14	CAPSULE / ORAL		150 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, FILM COATED / ORAL		91 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		357 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CAPSULE, EXTENDED RELEASE / ORAL		17 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SWAB / TOPICAL		5250 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, EXTENDED RELEASE / ORAL		1246 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET, COATED / ORAL		12 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL		1800 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION / OPHTHALMIC		46 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GRANULE, FOR SUSPENSION / ORAL		296 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, CHEWABLE / ORAL		1725 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, COATED PELLETS / ORAL		456 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CREAM / TOPICAL		80 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	PASTE, DENTIFRICE / DENTAL	0.4 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	INSERT, EXTENDED RELEASE / OPHTHALMIC	0.4 mg		Exact identifier — unii candidate 40 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A090837-001	FAMOTIDINE	FAMOTIDINE	20MG	TABLET / ORAL			2010-08-04

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A090837-001	FAMOTIDINE	20MG	TABLET / ORAL	2010-08-04	`3a93d1ddd44b…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
26d964f1-b9a8-8ecb-e063-6394a90ad73f			dd45b1fe-76f1-4486-9ec9-ad409208afb4	2024-11-14	Warnings	Exact identifier spl set id: dd45b1fe-76f1-4486-9ec9-ad409208afb4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.